Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-007946
Filing Date
2015-11-10
Accepted
2015-11-10 21:40:58
Documents
2
Period of Report
2015-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2813
2 EX-24 DOCUMENT attachment1.htm EX-24 5002
  Complete submission text file 0000899243-15-007946.txt   9387
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WAVE LIFE SCIENCES LTD. 733 CONCORD AVE. CAMBRIDGE MA 02138
Business Address
Moran Kyle (Reporting) CIK: 0001657765 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37627 | Film No.: 151220939